GL1X · GenesisL1 explorer

Research workbench

Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design

Analyse Crystal structures of native and inhibited forms of human cathepsin D… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1LYB
Type
protein
Length
686 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cathepsin D; Pepstatin
EC
3.4.23.5
UniProt
P07339
Ligands
IVA, NAG, BMA, MAN
Pockets
4 · best druggability 0.60

Structure

x-ray diffraction · 3 distinct chains · 15% helix, 45% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, CCathepsin D (EC 3.4.23.5)protein977% helix, 55% strandP07339
B, DCathepsin D (EC 3.4.23.5)protein24119% helix, 42% strandP07339
I, JPepstatinprotein50% helix, 20% strand—

Ligands and binding sites

  • IVA · Isovaleric acid · ligand · 2 copies · chains A, B, I, C, D, J
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 6 copies · chains A, B, C, D
  • BMA · beta-D-mannopyranose · sugar · 2 copies · chains B, D
  • MAN · alpha-D-mannopyranose · sugar · 2 copies · chains B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13760.600.7744empty
22470.540.7627IVA
32580.520.7527IVA
4560.270.7418empty

Interfaces

8 interfaces between chains.

  • C–D · 3291 Ų buried · 82 hydrogen bonds · protein-protein
  • A–B · 3277 Ų buried · 84 hydrogen bonds · protein-protein
  • D–J · 420 Ų buried · 6 hydrogen bonds · protein-protein
  • B–I · 397 Ų buried · 9 hydrogen bonds · protein-protein
  • C–J · 352 Ų buried · 10 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide, 4 glycan, 4 modified, 2 covalent (disulfide, N-glycosylation, nonstandard, covalent ligand).

Compared structures

  • 1LYB · Crystal structures of native and inhibited forms of human cathepsin D: implications for… · the same entry in another collection · chain J against J, TM-score 1.00
  • P07339 · AlphaFold monomer V2.0 prediction for cathepsin D (P07339) · a predicted model of the same protein · chain D against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.